Table 2 Oral antidiabetic prescriptions for dual therapy by treatment pathway, stratified by insurance scheme and type of therapy

Two-pill

Metformin + 

366,610

39.57

16,517

30.91

Sulfonylurea

191,093

20.62

6,118

11.45

DPP-IV-Inhibitor

95,408

10.30

7,355

13.77

Glinide

13,148

1.42

1,448

2.71

GLP-1 Agonists

11,385

1.23

1,459

2.73

Glitazones

2,874

0.31

848

1.59

AGI

5,945

0.64

460

0.86

SGLT2

4,007

0.43

506

0.95

G/S

45

0.00

9

0.02

Total two-pill

690,515

74.52

34,720

64.99

Single-pill

M-DPPIV

229,944

24.82

17,255

32.29

M-Glitazones

4,615

0.50

1,432

2.68

M-Sulfonylurea

1,444

0.16

24

0.04

Total single-pill

236,003

25.48

18,711

35.01

Observations

926,518

53,431

Patients

64,552

4,329